PUMA BIOTECHNOLOGY, INC. (PBYI)
Clinical trial NCT06095505 updates: 1. completion date: 2027-10-31 → 2028-04-30 2. primary completion date: 2027-04-30 → 2027-10-30 3. enrollment: 80 → 120 participants
Clinical trial NCT06095505 updates: 1. completion date: 2027-10-31 → 2028-04-30 2. primary completion date: 2027-04-30 → 2027-10-30 3. enrollment: 80 → 120 participants
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical